Christopher PRICE

Person

Monroe Township, NJ, US

People

Patents Applicationslast 30 patents

Information Patent Application
Dry Powdered Formulations
- Publication number 20250000806
- Publication date Jan 2, 2025
- Pinata Holdings Inc.
- Michael OGBURN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Delivery of Cellular Material and Other Material as a Dry Powder
- Publication number 20240366660
- Publication date Nov 7, 2024
- Pinata Holding Inc.
- Michael OGBURN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS
- Publication number 20240358650
- Publication date Oct 31, 2024
- Pinata Holdings Inc.
- Michael OGBURN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS
- Publication number 20240358649
- Publication date Oct 31, 2024
- Pinata Holdings Inc.
- Michael OGBURN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhalable Pharmaceutical Formulations
- Publication number 20240261227
- Publication date Aug 8, 2024
- Michael OGBURN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhalable Cannabinoid Formulations
- Publication number 20240050450
- Publication date Feb 15, 2024
- Michael OGBURN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oral Capsule Cannabinoid Formulations
- Publication number 20240041782
- Publication date Feb 8, 2024
- Michael OGBURN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhaled PDE-V Inhibitor Drugs
- Publication number 20230372345
- Publication date Nov 23, 2023
- Michael OGBURN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christopher PRICE

Person

Patents Applicationslast 30 patents

Dry Powdered Formulations

Delivery of Cellular Material and Other Material as a Dry Powder

INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS

INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS

Inhalable Pharmaceutical Formulations

Inhalable Cannabinoid Formulations

Oral Capsule Cannabinoid Formulations

Inhaled PDE-V Inhibitor Drugs